AnaptysBio, Inc. (ANAB) vs Kardigan, Inc. (KARD)
A side-by-side comparison of AnaptysBio, Inc. and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANAB
AnaptysBio, Inc.
$47.62HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
KARD
Kardigan, Inc.
$13.81HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT
Total return — ANAB vs KARD
growth of $100 · dividends reinvested · last 1yANAB -14.4% (-14.4%/yr)KARD -30.7% (-30.7%/yr)ANAB compounded faster over this window
ANAB KARD
ANAB vs KARD: by the numbers
- •ANAB is the larger company ($1.41B vs $1.23B market cap).
- •ANAB is profitable (82.37% net margin) while KARD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ANAB | KARD |
|---|---|---|
| P/E ratio | 8.87 | N/A |
| P/S ratio | 5.93 | N/A |
| P/B ratio | 133.20 | 2.00 |
| EV / EBITDA | 11.39 | N/A |
| FCF yield | 1.28% | N/A |
Profitability
| Metric | ANAB | KARD |
|---|---|---|
| Gross margin | 98.97% | 0.00% |
| Operating margin | 20.42% | 0.00% |
| Net margin | 82.37% | 0.00% |
| ROE | 1849.06% | N/A |
| ROIC | 47.55% | -57.11% |
Growth (annualized)
| Metric | ANAB | KARD |
|---|---|---|
| Revenue CAGR (5Y) | 18.60% | N/A |
| FCF CAGR (5Y) | 27.41% | N/A |
| Total return CAGR (5Y) | 21.54% | N/A |
Frequently asked
- Is ANAB or KARD more profitable?
- ANAB runs the higher net margin — ANAB at 82.37% versus KARD at 0.00%.
Go deeper
Dig into the metrics
AnaptysBio P/E ratioAnaptysBio ROEKardigan ROEAnaptysBio operating marginKardigan operating marginAnaptysBio revenue growthKardigan revenue growthAnaptysBio free cash flowKardigan free cash flow
AnaptysBio & Kardigan appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.